Development of para-amino salicylic acid minitablets for controlled release drug delivery

Main Article Content

Wannisa Srichamnong
Jomjai Peerapattana

Abstract

The aim of this experiment is to develop enteric coated para-amiosalicylic acid (PAS) in the form
of multiple unit dosage forms. The minitablets were prepared by wet granulation method. The characteristics of
these small units were studied include hardness, friability, weight variation and content uniformity. Coteric®L
100 was used as a film former. Desired film properties were adjusted by addition of plasticizer and glidant . Pan
coater with nozzle is used in this study. Coated minitablets were filled into capsule for PAS equivalent to 300
mg. The physical properties of enteric coated minitablets was evaluated. The drug release of minitablets were
performed in 0.1 N HCl for the first 2 hours and replaced with phosphate buffer pH 6.8 for another 2 hours.
The obtained core minitablets had average weight 0.050 g, standard deviation was 1.62, percentage of
friability was 1.44 and percent labeled amout was 101.26. The enteric coated minitablets released 1.39% PAS
in 0.1 N HCl and 81.10% in phosphate buffer pH 6.8 within 45 minutes. These properties are complied with
the USP 29 regulation of which in 0.1 N HCl no individual value exceeds 10% and in phosphate buffer pH
6.8 dissolved not than 75% within 45 minutes.

Downloads

Download data is not yet available.

Article Details

Section
Pharmaceutical Sciences

References

Akhtar A. J., Crompton G. K., and Schonell M. E.,Malabsorption Induced by P.A.S. Br Med J.17(1969): 449.
Aleksandra D, Raoul M, Peter A, Paul F, Jan G.Developement of starch-based pellets viaextrusion/spheronisation. European Journal of Pharmaceutics and Biopharmaceutics.66(2007): 83-94
Bodmeier R. Tableting of coated pellets. European Journal of Pharmaceutics and Biopharmaceutics. 43 (1997): 1-8
Melia, C.D., 1994. An introduction to oral multiparticulate dosage forms. In: C.D. MELIA,N. WASHINGTON and C.G. WILSON, eds. Multiparticulate oral dosage forms: technology and biopharmaceutics. Edinburgh: Scottish Academic Press.
Palwatwichai A. Tuberculosis in Thailand. Respirology.6(2001): 65-70
Peloquin CA, Henshaw TL, Huitt GA, et al. Pharma-cokinetic evaluation of para-aminosalicylic acid granules. Pharmacotherapy. 14(1994):40-46.
The United States U.S. Pharmacopeia Convention. The United States Pharmacopeia 29 The National Formula. 2006
Umubyeyi A. et al. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. International Journal of Infectious Diseases. 12(2008): 15-156